Brain-disabling treatments in psychiatry: drugs, electroshock, and the role of the FDA
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
Springer
1997
|
| Schlagworte: | |
| Beschreibung: | XII, 306 S. Ill. |
| ISBN: | 0826194907 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV011696198 | ||
| 003 | DE-604 | ||
| 005 | 20240411 | ||
| 007 | t | ||
| 008 | 971223s1997 a||| |||| 00||| eng d | ||
| 020 | |a 0826194907 |9 0-8261-9490-7 | ||
| 035 | |a (OCoLC)36225974 | ||
| 035 | |a (DE-599)BVBBV011696198 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a RC483 | |
| 082 | 0 | |a 616.89/1 |2 21 | |
| 100 | 1 | |a Breggin, Peter R. |d 1936- |e Verfasser |0 (DE-588)1053062370 |4 aut | |
| 245 | 1 | 0 | |a Brain-disabling treatments in psychiatry |b drugs, electroshock, and the role of the FDA |c Peter R. Breggin |
| 264 | 1 | |a New York |b Springer |c 1997 | |
| 300 | |a XII, 306 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Elektroshocktherapie |2 gtt | |
| 650 | 7 | |a Hersenbeschadiging |2 gtt | |
| 650 | 7 | |a Iatrogene ziekten |2 gtt | |
| 650 | 7 | |a Psychofarmaca |2 gtt | |
| 650 | 4 | |a Brain Damage, Chronic |x etiology |z United States |v Legislation | |
| 650 | 4 | |a Brain damage |x Etiology | |
| 650 | 4 | |a Brain |x Effect of drugs on | |
| 650 | 4 | |a Drug Industry |z United States |v Legislation | |
| 650 | 4 | |a Electroconvulsive Therapy |x adverse effects |z United States |v Legislation | |
| 650 | 4 | |a Electroconvulsive therapy |x Complications | |
| 650 | 4 | |a Iatrogenic diseases | |
| 650 | 4 | |a Mental Disorders |x therapy |z United States |v Legislation | |
| 650 | 4 | |a Psychotropic Drugs |x adverse effects |z United States |v Legislation | |
| 650 | 4 | |a Psychotropic drugs |x Side effects | |
| 650 | 0 | 7 | |a Psychische Störung |0 (DE-588)4047686-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Komplikation |0 (DE-588)4123547-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Medizinschaden |0 (DE-588)4201836-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hirnschädigung |0 (DE-588)4072519-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Elektrokrampftherapie |0 (DE-588)4151821-4 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 689 | 0 | 0 | |a Elektrokrampftherapie |0 (DE-588)4151821-4 |D s |
| 689 | 0 | 1 | |a Komplikation |0 (DE-588)4123547-2 |D s |
| 689 | 0 | 2 | |a Hirnschädigung |0 (DE-588)4072519-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 1 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 1 | 2 | |a Hirnschädigung |0 (DE-588)4072519-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Psychische Störung |0 (DE-588)4047686-8 |D s |
| 689 | 2 | 1 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 2 | 2 | |a Medizinschaden |0 (DE-588)4201836-5 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Psychische Störung |0 (DE-588)4047686-8 |D s |
| 689 | 3 | 1 | |a Elektrokrampftherapie |0 (DE-588)4151821-4 |D s |
| 689 | 3 | 2 | |a Medizinschaden |0 (DE-588)4201836-5 |D s |
| 689 | 3 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007887455 | ||
Datensatz im Suchindex
| _version_ | 1804126234273120256 |
|---|---|
| any_adam_object | |
| author | Breggin, Peter R. 1936- |
| author_GND | (DE-588)1053062370 |
| author_facet | Breggin, Peter R. 1936- |
| author_role | aut |
| author_sort | Breggin, Peter R. 1936- |
| author_variant | p r b pr prb |
| building | Verbundindex |
| bvnumber | BV011696198 |
| callnumber-first | R - Medicine |
| callnumber-label | RC483 |
| callnumber-raw | RC483 |
| callnumber-search | RC483 |
| callnumber-sort | RC 3483 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)36225974 (DE-599)BVBBV011696198 |
| dewey-full | 616.89/1 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.89/1 |
| dewey-search | 616.89/1 |
| dewey-sort | 3616.89 11 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02835nam a2200733 c 4500</leader><controlfield tag="001">BV011696198</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240411 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">971223s1997 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0826194907</subfield><subfield code="9">0-8261-9490-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)36225974</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011696198</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC483</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89/1</subfield><subfield code="2">21</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Breggin, Peter R.</subfield><subfield code="d">1936-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1053062370</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Brain-disabling treatments in psychiatry</subfield><subfield code="b">drugs, electroshock, and the role of the FDA</subfield><subfield code="c">Peter R. Breggin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Springer</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 306 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Elektroshocktherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hersenbeschadiging</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Iatrogene ziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychofarmaca</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain Damage, Chronic</subfield><subfield code="x">etiology</subfield><subfield code="z">United States</subfield><subfield code="v">Legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain damage</subfield><subfield code="x">Etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain</subfield><subfield code="x">Effect of drugs on</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield><subfield code="v">Legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Electroconvulsive Therapy</subfield><subfield code="x">adverse effects</subfield><subfield code="z">United States</subfield><subfield code="v">Legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Electroconvulsive therapy</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Iatrogenic diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield><subfield code="x">therapy</subfield><subfield code="z">United States</subfield><subfield code="v">Legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic Drugs</subfield><subfield code="x">adverse effects</subfield><subfield code="z">United States</subfield><subfield code="v">Legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Komplikation</subfield><subfield code="0">(DE-588)4123547-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinschaden</subfield><subfield code="0">(DE-588)4201836-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hirnschädigung</subfield><subfield code="0">(DE-588)4072519-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Elektrokrampftherapie</subfield><subfield code="0">(DE-588)4151821-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Elektrokrampftherapie</subfield><subfield code="0">(DE-588)4151821-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Komplikation</subfield><subfield code="0">(DE-588)4123547-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Hirnschädigung</subfield><subfield code="0">(DE-588)4072519-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Hirnschädigung</subfield><subfield code="0">(DE-588)4072519-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Medizinschaden</subfield><subfield code="0">(DE-588)4201836-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Elektrokrampftherapie</subfield><subfield code="0">(DE-588)4151821-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Medizinschaden</subfield><subfield code="0">(DE-588)4201836-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007887455</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV011696198 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:14:13Z |
| institution | BVB |
| isbn | 0826194907 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007887455 |
| oclc_num | 36225974 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XII, 306 S. Ill. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Springer |
| record_format | marc |
| spelling | Breggin, Peter R. 1936- Verfasser (DE-588)1053062370 aut Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA Peter R. Breggin New York Springer 1997 XII, 306 S. Ill. txt rdacontent n rdamedia nc rdacarrier Elektroshocktherapie gtt Hersenbeschadiging gtt Iatrogene ziekten gtt Psychofarmaca gtt Brain Damage, Chronic etiology United States Legislation Brain damage Etiology Brain Effect of drugs on Drug Industry United States Legislation Electroconvulsive Therapy adverse effects United States Legislation Electroconvulsive therapy Complications Iatrogenic diseases Mental Disorders therapy United States Legislation Psychotropic Drugs adverse effects United States Legislation Psychotropic drugs Side effects Psychische Störung (DE-588)4047686-8 gnd rswk-swf Komplikation (DE-588)4123547-2 gnd rswk-swf Medizinschaden (DE-588)4201836-5 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Hirnschädigung (DE-588)4072519-4 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Elektrokrampftherapie (DE-588)4151821-4 gnd rswk-swf USA Elektrokrampftherapie (DE-588)4151821-4 s Komplikation (DE-588)4123547-2 s Hirnschädigung (DE-588)4072519-4 s DE-604 Psychopharmakon (DE-588)4047729-0 s Arzneimittelnebenwirkung (DE-588)4003134-2 s Psychische Störung (DE-588)4047686-8 s Medizinschaden (DE-588)4201836-5 s |
| spellingShingle | Breggin, Peter R. 1936- Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA Elektroshocktherapie gtt Hersenbeschadiging gtt Iatrogene ziekten gtt Psychofarmaca gtt Brain Damage, Chronic etiology United States Legislation Brain damage Etiology Brain Effect of drugs on Drug Industry United States Legislation Electroconvulsive Therapy adverse effects United States Legislation Electroconvulsive therapy Complications Iatrogenic diseases Mental Disorders therapy United States Legislation Psychotropic Drugs adverse effects United States Legislation Psychotropic drugs Side effects Psychische Störung (DE-588)4047686-8 gnd Komplikation (DE-588)4123547-2 gnd Medizinschaden (DE-588)4201836-5 gnd Psychopharmakon (DE-588)4047729-0 gnd Hirnschädigung (DE-588)4072519-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Elektrokrampftherapie (DE-588)4151821-4 gnd |
| subject_GND | (DE-588)4047686-8 (DE-588)4123547-2 (DE-588)4201836-5 (DE-588)4047729-0 (DE-588)4072519-4 (DE-588)4003134-2 (DE-588)4151821-4 |
| title | Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA |
| title_auth | Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA |
| title_exact_search | Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA |
| title_full | Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA Peter R. Breggin |
| title_fullStr | Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA Peter R. Breggin |
| title_full_unstemmed | Brain-disabling treatments in psychiatry drugs, electroshock, and the role of the FDA Peter R. Breggin |
| title_short | Brain-disabling treatments in psychiatry |
| title_sort | brain disabling treatments in psychiatry drugs electroshock and the role of the fda |
| title_sub | drugs, electroshock, and the role of the FDA |
| topic | Elektroshocktherapie gtt Hersenbeschadiging gtt Iatrogene ziekten gtt Psychofarmaca gtt Brain Damage, Chronic etiology United States Legislation Brain damage Etiology Brain Effect of drugs on Drug Industry United States Legislation Electroconvulsive Therapy adverse effects United States Legislation Electroconvulsive therapy Complications Iatrogenic diseases Mental Disorders therapy United States Legislation Psychotropic Drugs adverse effects United States Legislation Psychotropic drugs Side effects Psychische Störung (DE-588)4047686-8 gnd Komplikation (DE-588)4123547-2 gnd Medizinschaden (DE-588)4201836-5 gnd Psychopharmakon (DE-588)4047729-0 gnd Hirnschädigung (DE-588)4072519-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Elektrokrampftherapie (DE-588)4151821-4 gnd |
| topic_facet | Elektroshocktherapie Hersenbeschadiging Iatrogene ziekten Psychofarmaca Brain Damage, Chronic etiology United States Legislation Brain damage Etiology Brain Effect of drugs on Drug Industry United States Legislation Electroconvulsive Therapy adverse effects United States Legislation Electroconvulsive therapy Complications Iatrogenic diseases Mental Disorders therapy United States Legislation Psychotropic Drugs adverse effects United States Legislation Psychotropic drugs Side effects Psychische Störung Komplikation Medizinschaden Psychopharmakon Hirnschädigung Arzneimittelnebenwirkung Elektrokrampftherapie USA |
| work_keys_str_mv | AT bregginpeterr braindisablingtreatmentsinpsychiatrydrugselectroshockandtheroleofthefda |